Levi & korsinsky reminds regeneron pharmaceuticals, inc. investors of the pending class action lawsuit with a lead plaintiff deadline of march 10, 2025 – regn

New york, march 07, 2025 (globe newswire) -- levi & korsinsky, llp notifies investors in regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) of a class action securities lawsuit.

REGN Ratings Summary

REGN Quant Ranking